1. Market Research
  2. > Pharmaceutical Market Trends
Pharmaceutical Isolator Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Pressure, Configuration, Application, and End User ; and Geography

Pharmaceutical Isolator Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type, Pressure, Configuration, Application, and End User ; and Geography

  • August 2021
  • 202 pages
  • ID: 6154058
  • Format: PDF
  • The Insight Partners

Summary

Table of Contents

Search Inside

The pharmaceutical isolator market was valued at 5,966.07 million in 2021 and is projected to reach US$ 10,560.30 million by 2028; it is expected to grow at a CAGR of 8.5 % from 2021 to 2028.
The growth of the pharmaceutical isolator market is attributed to factors such as an increase in investments by the pharmaceutical and biotechnology industry and a regulatory framework to support the adoption of pharmaceutical isolators. However, the market is likely to get impacted by the high cost involved in the operation and maintenance of pharmaceutical isolators.

A pharmaceutical isolator is a device that keeps a pharmaceutical process or activity isolated from the operator and the rest of the world.This might be for the aim of safeguarding a process or activity from microbiological and/or nonviable contamination caused by the operator and the surrounding environment by creating a classified clean or classified aseptic environment.

This is referred to as product protection.Moreover, it can be used in protecting the operator and the surrounding environment from hazards arising from the process or activity.

This is referred to as “operator protection” or “containment.”

A pharmaceutical isolator offers a superior sterile environment than conventional clean rooms.Positive or negative pressures inside the chamber prevent contamination due to operator interference.

It ensures long-lasting sterility in accordance with pharmaceutical regulations related to the manufacturing of sterile medical products.Moreover, most of the experts agree that regulatory agencies are no longer impeding progress when it comes to technologies such as pharmaceutical isolators.

The guidelines set by the US Food and Drug Administration (US FDA) and the European Medicines Agency regarding isolators play an important role in the adoption of isolators in comparison to cleanrooms.FDA mentions isolators 55 times in its latest guideline of manufacturing in an aseptic environment.

A well-designed positive pressure isolator, supported by adequate procedures for its maintenance, monitoring, and controls, offers significant advantages over traditional aseptic processing, including fewer opportunities for microbial contamination during processing. Moreover, FDA acknowledges the removal of operators in the critical areas of pharmaceutical manufacturing, which is expected to propel the adoption of pharmaceutical isolators in the coming years. Trend analysis shows an increasing number of pharmaceutical facilities using isolator technology in the US. In 1998, only 84 facilities were equipped with aseptic filling in isolators. This number increased to 174 facilities in 2000, 201 in 2002, and 258 in 2004. The growth in the number of facilities offering aseptic processing is related to the growth in the production of high-potency drugs. Hence, a supportive regulatory framework will increase the adoption of pharmaceutical isolators and subsequently drive the market.
The COVID-19 pandemic has become the most significant challenge across the world.It has disturbed various trades and businesses across the world.

However, the pandemic has brought several growth opportunities to the pharmaceutical and biopharmaceutical companies to strengthen their research and development for innovating vaccines against the novel coronavirus.The companies are performing clinical trials to curb the spread of the COVID-19 virus.

Thus, increased clinical trials will lead to vital opportunities for the pharmaceutical isolator providers for biopharmaceutical companies.
Based on type, the pharmaceutical isolator market is segmented into open isolator and closed isolator. The open isolator segment held a larger share of the market in 2021, and the same segment is anticipated to register a higher CAGR in the market during the forecast period.

Based on pressure, the pharmaceutical isolator market is segmented into positive pressure and negative pressure. In 2021, the positive pressure segment held a larger share of the market; however, the negative pressure segment is expected to grow at the fastest rate during the forecast period.

Based on configuration, the pharmaceutical isolator market is segmented into floor standing, modular, mobile, compact, tabletop, and portable.The floor standing segment is likely to hold the largest share of the market, and the same segment is anticipated to register the highest CAGR in the market during the forecast period.

Growth of the floor standing segment is attributed to improved efficiency, coupled with more quick operations.

Based on application, the pharmaceutical isolator market is segmented into aseptic isolators, containment isolators, sampling and weighing isolators, fluid dispensing isolators, and others.The aseptic isolator segment is likely to hold the largest share of the market.

Also, the same segment is anticipated to register the highest CAGR in the market during the forecast period.

Based on end user, the pharmaceutical isolator market is segmented into hospitals, pharmaceutical and biotechnology companies, research and academic laboratories, and others. The pharmaceutical and biotechnology companies’ segment is likely to hold the largest share of the market, and the same segment is anticipated to register the highest CAGR in the market during the forecast period.
The European Union, National Health Service, The Food and Drug Administration, The World Health Organization, National Center for Biotechnology Information, Pharmaceutical and Medical Devices Agency, and Organization for Economic Co-operation and Development are among the major primary and secondary sources referred to while preparing this report.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Pharmaceutical Contract Development and Manufacturing Market, End User -Global Forecast to 2026

  • $ 4950
  • October 2021
  • 242 pages

The global pharmaceutical contract development and manufacturing market is projected to reach USD 171.3 billion by 2026 from USD 120.6 billion in 2021, at a CAGR of 7.3% during the forecast period. Market ...

  • World
  • India
  • Pharmaceutical
  • Industry analysis
  • Pharmaceutical Production
  • Health Expenditure

ref:plp2021

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on